News
Early Bird Registration ends on 8 July 11.59pm CEST!
https://esdrmeeting.org/registration/ Don't miss your chance to save up to €195 on your...
2026 ISID-LEO Foundation Awards EMEA Region
ISID and LEO Foundation Partner to Expand Global Reach of Early-Career Awards Inaugural...
An exceptional result!
Thank you to our incredible research community for this outstanding response. Whether you...
ESDR2026 confirmed keynotes speakers
Dear Colleagues, dear Friends, We are delighted to announce that our keynote speakers and...
2026 abstracts submission is open
Dear colleague, We are pleased to announce that abstract submission for the 55th Annual ESDR...
Women in Science by ESDR
This 11 February, on the International Day of Women and Girls in Science, ESDR launches Women in...
About The ESDR
The European Society for Dermatological Research (ESDR), founded in 1970, is a non-profit organization promoting basic and clinical science related to dermatology. The ESDR is the largest investigative dermatology society in Europe with a current membership of over 1200.
By supporting investigative dermatology, the ESDR contributes towards improving the health of patients suffering from skin and venereal disease. Applications of recent scientific advances have produced diagnostic and therapeutic innovations in dermatological practice, particularly in genetics, skin cancer, allergic skin disease, infectious disease and autoimmune diseases.
ABOUT JID
The Journal of Investigative Dermatology (JID) is the official journal of the ESDR and SID. JID publishes papers describing original research on all aspects of cutaneous biology and skin disease. Topics include biochemistry, biophysics, cell regulation, carcinogenesis, skin structure, extracellular matrix, genetics, immunology, melanocyte biology, microbiology, molecular and cell biology, pathology, physiology, pharmacology, photobiology, percutaneous absorption, clinical research, epidemiology and other population-based research.
JID Latest
- Sensory neurons shape γδ T cell effector programs to control psoriasiform inflammation
- Genomic and spatial transcriptomics identify fibroblast-associated microenvironment in early mycosis fungoides progression
- Reframing hidradenitis suppurativa through basic and translational science
- 0359 Psoriasis and metabolic indices: A systematic review of risk, severity, and complications
- LB1079 Abrocitinib reduces tissue-resident memory T cells and restores epidermal barrier in atopic dermatitis: Results from JADE MOA trial
